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ABSTRACT
Prenatal ethanol exposure is associated with an increased incidence of depressive disorders in
patient populations. However, the mechanisms that link prenatal ethanol exposure and
depression are unknown. Several recent studies have implicated reduced brain-derived
neurotrophic factor (BDNF) levels in the hippocampal formation and frontal cortex as important
contributors to the etiology of depression. In the present studies, we sought to determine
whether prenatal ethanol exposure is associated with behaviors modeling depression, as well as
with reduced BDNF levels in the hippocampal formation and/or medial frontal cortex, in a
mouse model of fetal alcohol spectrum disorder (FASD). Compared to control adult mice,
prenatal ethanol-exposed adult mice displayed increased learned helplessness behavior and
increased immobility in the Porsolt forced swim test. Prenatal ethanol exposure was associated
with decreased BDNF protein levels in the medial frontal cortex, but not the hippocampal
formation, while total BDNF mRNA and BDNF transcripts containing exon III, IV or VI were
reduced in both the medial frontal cortex and the hippocampal formation of ethanol-exposed
mice. These results identify reduced BDNF levels in the medial frontal cortex and hippocampal
formation as potential mediators of depressive disorders associated with FASD.

Keywords: BDNF, hippocampus, frontal cortex, prenatal, ethanol, depression
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INTRODUCTION
Prenatal ethanol exposure has been shown to be associated with a spectrum of neurochemical,
physiologic, and behavioral dysfunctions that affect various aspects of an individual’s life. The
range of clinical abnormalities that are associated with prenatal ethanol exposure is termed fetal
alcohol spectrum disorder (FASD). The incidence of FASD is estimated to be as high as 1 in
100 births (Sampson et al., 1997). Although the most common manifestation of FASD is a
reduction in cognitive abilities (Sampson et al., 1997; Streissguth and O’Malley, 2000), FASD is
also comorbid with various psychiatric illnesses, including depression (Famy et al., 1998;
O’Connor and Kasari, 2000; O’Connor et al., 2002; O’Connor and Paley, 2006; Roebuck et al.,
1999). Several genetic and biochemical abnormalities have been shown to be associated with
depression (Berton and Nestler, 2006; Duman and Monteggia, 2006; Hasler et al., 2007; Jans et
al., 2007; Levinson, 2006); however, none of these has been implicated as a mechanism linking
prenatal ethanol exposure and depressive disorders. Therefore, we investigated the relationship
between one of these potential mechanisms, reductions in brain-derived neurotrophic factor
(BDNF) levels, and prenatal ethanol exposure-associated depression in a mouse model of FASD.
Several lines of evidence indicate that reduced BDNF levels in the prefrontal cortex,
hippocampus, or both play an important role in depression. BDNF expression is diminished in
postmortem hippocampus and prefrontal cortex collected from suicide cases with untreated
depression compared to patients who were being treated with antidepressants at the time of
suicide (Chen et al., 2001; Karege et al., 2005). Experimental paradigms, such as learned
helplessness and the forced swim task, which induce behaviors modeling depression in
laboratory animals, have been shown to cause reductions in BDNF protein and mRNA levels in
the frontal cortex and/or hippocampus (Itoh et al., 2004; Russo-Neustadt et al., 2001; Song et al.,
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2006; Takeda et al., 2006). Additionally, elevated BDNF protein levels have been shown to
block depressive behaviors in these same paradigms (Shirayama et al., 2002; Siuciak et al.,
1997). Finally, long-term antidepressant therapy has been shown to increase BDNF levels in the
hippocampus (Nibuya et al., 1995; Okamoto et al., 2003; Dwivedi et al., 2006) and frontal cortex
(Altar et al., 2003; Okamoto et al., 2003). These results, combined with the observation that
therapeutic responses to antidepressants generally require chronic administration of the drugs,
have led to the “neurotrophic hypothesis” of depression (reviewed in Duman and Monteggia,
2006).
Prenatal exposure to ethanol has been reported to either decrease or have no effect on BDNF
protein levels measured in the postnatal rat brain. Heaton et al. (2000) reported that prenatal
ethanol exposure did not affect BDNF protein levels measured in hippocampal formation or the
cortex/striatum on postnatal day 1. Feng et al. (2005) found that prenatal ethanol exposure
reduced BDNF protein levels in postnatal day 7 and 8 cortex and hippocampal formation.
Similarly, Climent et al. (2002) reported that prenatal ethanol exposure reduced BDNF protein
levels in the cortex, when measured on postnatal days 5-21, while pups were being nursed by
ethanol-consuming moms; however, levels were not different from controls on postnatal day 35
after weaning. We are unaware of any published studies on the effects of prenatal ethanol
exposure on BDNF levels in the brains of adult rodents.
The studies described herein demonstrate that adult mice that were exposed to ethanol
throughout gestation display depressive behaviors, manifested as augmented learned helplessness
and immobility in the forced swim test. In addition, we found that prenatal exposure to ethanol
was associated with reduced levels of BDNF protein, as well as mRNA, in the frontal cortex and
reduced BDNF mRNA levels in the hippocampal formation. These studies demonstrate that
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clinical depression displayed by diagnosed FASD patients is replicated in an FASD mouse
model and identify neurochemical alterations that may underlie this disorder.
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MATERIALS AND METHODS
Animals: All animal procedures employed in these studies were approved by the University of
New Mexico Institutional Animal Care and Use Committee.
Prenatal Ethanol Exposure Paradigm: The procedures employed for prenatal ethanol exposure
were essentially as described in Allan et al. (2003). Briefly, female C57BL/6J mice (The
Jackson Laboratory; Bar Harbor, ME) were offered 22 hr free access to either 0.066% saccharin
or water for 1 week. Following this period, ethanol was introduced to the saccharin tube for the
ethanol group, while the control group continued to have access to saccharin alone. The ethanol
concentration was increased from 0% to 5% in a stepwise fashion over five days. After two
weeks of stable drinking, females were placed on breeder chow and a male was introduced into
the female’s cage. Once the female was determined to be pregnant, the male was removed,
nesting material was added to the cage, and the female continued to consume ethanol or
saccharin. Ethanol consumption was measured every other day and the g ethanol consumed / kg
body weight / day were calculated for each dam. Within one day of birth, the ethanol and the
saccharin concentrations were reduced by one-half every two days until the mice were
consuming water. We have found that this procedure yields maternal care behaviors that are
indistinguishable between saccharin- and ethanol-consuming moms (Allan et al., 2003) and,
thus, avoids the introduction of the confound of poor maternal care that can occur with
postpartum maternal consumption of ethanol or sudden ethanol withdrawal. Pups were weaned
at 23-25 days and maintained in same-sex and litter-mate cages, 3-4 mice per cage, with free
access to water and chow until adulthood.
Measurement of Blood Ethanol Concentrations: Maternal blood ethanol concentrations were
determined as previously described (Allan et al., 2003). Blood samples were collected from
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mice that were approximately 14 days pregnant during the middle of the drinking period. These
measures were performed on a separate group of dams that were drinking at a rate similar to that
of the dams whose offspring were used in the present studies.
Behavioral Testing Procedures: Mice were maintained on a 12 hr light : 12 hr dark cycle (lights
on 7:00 AM). Behavioral testing was conducted between 9 AM and 3 PM. All studies were
performed using female mice between 60 and 90 days of age at the time of testing. Animals
were used in only one of the two behavioral tests. Additionally, none of the animals used in the
behavioral studies were used for the biochemical and molecular analyses, which were performed
on naïve mice.
Learned helplessness: The apparatus for the learned helplessness task consisted of a
Coulbourn™ Habitest© shuttlebox with a stainless steel grid floor for administration of the
footshock. The apparatus was located within a sound-attenuated chamber. 70% isopropanol was
used to clean the walls and floor after the removal of each mouse from the shuttlebox.
The method for assessing learned helplessness was modified from Caldarone et al. (2004). On
Day 1, animals received 20 uncontrollable and unpredictable footshocks (0.5 mA, 2 second
duration); the probability for delivery of the footshock was assigned at 0.5 every 15 seconds.
The animal was removed 30 seconds after the delivery of the last shock and returned to its home
cage. We note that, although many published procedures for the production of learned
helplessness employ more than 100 inescapable footshocks to an animal (Caldarone et al., 2000;
Caldarone et al., 2004; MacQueen et al., 2001; Newton et al., 2002; Ridder et al., 2005; SchulteHerbrüggen et al., 2006), we were able to identify increased levels of learned helplessness in
prenatal ethanol-exposed mice with the use of this milder procedure. On the testing day (Day 2),
animals experienced 28 test trials with an intertrial interval of 30 seconds. For the first five
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trials, a footshock (0.5 mA) and auditory cue (80 dB, 6 Hz clicker) both began at the start of the
trial; after a one second delay, the guillotine door separating the two chambers of the shuttlebox
opened. The last 23 trials initiated with the tone and the door rising, and the onset of the
footshock was delayed for three seconds. Sensors in each compartment of the shuttlebox turned
off the footshock and tone and closed the guillotine door, if the animal escaped through the
raised door. If an escape was not made within 24 seconds from the initiation of the trial, the
shock and tone terminated and the door closed. The subject’s response in each trial was scored
as an “escape”, if it fled through the door to the non-shock side of the chamber within the 24 sec
test session, or as a “failure to escape”, if the animal remained in the side of the apparatus in
which the shock was being delivered. In addition, latency for the mouse to escape through the
door was measured as the time from the door rising to the time it closed. Curve fitting was
performed using Graph Pad Prism (version 4).
Forced swim test: Mice were placed in a 30 cm diameter, 46 cm tall cylinder of water (22-25°C,
depth 26 cm) for three minutes, as described previously (Porsolt et al., 1977; Sunal et al., 1994).
Six behaviors were assessed every five seconds during the last two minutes of the session, as
described by Schramm et al. (2001): floating, twitching, kicking, swimming, climbing, and
thrashing. The combination of floating, twitching and kicking behaviors was used as an index of
immobility, with the remaining behaviors representing escape-directed behavior. Data were
analyzed by Analysis of Variance (ANOVA) with the aid of SPSS (v.14) computer program.
Determination of BDNF protein levels: BDNF protein levels were determined in 96-well ELISA
plates (Chemicon, Temecula, CA), as described by the manufacturer.
Determination of proBDNF levels: The hippocampal formation and medial frontal cortex were
isolated, then homogenized in 0.5 mL ice-cold homogenization buffer (Buckley et al., 2004) and
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centrifuged (1,000 xgmax, 6 min, 4 oC). The supernatant was decanted and the pellet resuspended,
homogenized and centrifuged as before. The supernatant from the second centrifugation step
was combined with the initial supernatant and frozen in aliquots at -80 oC until use. Samples (30
μg medial frontal cortex; 70 μg hippocampal formation) were thawed, diluted in 4X SDS-PAGE
Sample Buffer containing NuPAGE Reducing Agent (Invitrogen Corporation, Carlsbad, CA) and
separated on 12% NuPAGE Bis-Tris Polyacrylamide Gels (Invitrogen Corporation) using MOPS
SDS Running Buffer containing NuPAGE Antioxidant (Invitrogen Corporation). Proteins were
transferred to PVDF (Bio-Rad Laboratories, Hercules, CA) membranes in NuPAGE Transfer
Buffer (Invitrogen Corporation) containing NuPAGE Antioxidant and methanol. The membranes
were blocked with 3% (w/v) BSA in TTBS [150 mM NaCl, 20 mM Tris (pH 7.5), 0.05% (v/v)
Tween 20] for 60 minutes at room temperature, then incubated overnight with affinity purified
anti-proBDNF rabbit antibody (Chemicon #AB5613P; 0.25 μg/mL) in BSA/TTBS at 4°C. The
membrane was washed 4 X 5 min with TTBS and incubated with HRP-conjugated secondary
antibody (HRP-Goat-Anti-Mouse-Anti-IgG (H + L); Jackson ImmunoResearch) in BSA/TTBS
for 90 minutes at room temp. The membrane was washed 4 X 5 min with TTBS and
immunoreactivity detected using a Supersignal West Pico Chemiluminescent Kit (Pierce
Biotechnology Inc). Luminescence was detected with film, digitized and quantified. Arbitrary
units of immunoreactivity were assigned based on the measured object density divided by the
amount of protein loaded onto the gel.
mRNA isolation: mRNA was isolated using the Oligotex Direct mRNA Mini Kit (Qiagen,
Valencia, CA) according to the manufacturer’s protocol. The mRNA concentration was
determined (OD 260 nm) using a NanoDrop® ND-1000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE). Purified mRNA was stored at -80 oC
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cDNA synthesis: Reverse transcription reactions were performed in 20 µL following the
manufacturer’s protocol. Briefly, a 10 µL reaction mixture containing 10 ng mRNA, 500 ng
oligo dT, 1 mM each dNTP was heated at 65 oC for 5 minutes and chilled on ice for 5 minutes,
followed by addition of 1 µL (200 units) M-MLV reverse transcriptase, 1 µL RNaseOUT (40
units/µL), 2µL DTT (0.1M) and sterile RNAase free water to 20µL. The whole reaction mixture
was incubated at 37 oC for 50 minutes, then 75 oC for 10 minutes. The synthesized cDNA was
stored at -20 oC until used. The suitability of the cDNA for PCR was determined using 2 μL of
cDNA added to a 40 µL PCR. A control reaction containing 2µl of purified mRNA was run
without reverse transcription to test for presence of DNA contamination in the purified mRNA
samples. The PCR was analyzed on a 2% (w/v) agarose gel.
Primers: Oligonucleotide sequences (Table 1) specific to mouse BDNF Exons I-IV, VI and IX,
and to cyclophilin A, 18S rRNA, hypoxanthine phosphoribosyltransferase 1 (HPRT1), and β
actin were designed using Primer Express software (Applied Biosystems, Foster City, CA). The
primers used for BDNF exon I, II, IV, and VI were based on sequences reported by Tsankova et
al (2006). The specificity of each primer pair was confirmed by the identification of a single
PCR product of predicted size on agarose gels followed by sequencing of the excised band
(sequencing performed by the UNM Proteomic and Molecular Biology Core facility).
Semi-quantitative determination of transcript levels by Real Time-PCR: Real time PCR was
conducted in a Gene Amp 7700 sequence detection system (Applied Biosystems) using a 96-well
plate (MicroAmp™ Fast Optical 96-well Reaction plates and MicroAmp™ Optical Adhesive
Film, both from Applied Biosystems). Reactions were performed in triplicate. Each 20 µL
reaction contained forward and reverse primers (100 nM each, final concentration), 10 µL Power
Sybr® Green PCR Master Mix reaction buffer (Applied Biosystems) and 2 µL cDNA.
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Following one initial step of 95 oC for 10 minutes, the cycling parameters were 95 oC for 15 sec,
60 oC for 1 min, and 40 cycles. The PCR products were monitored by measuring the increase in
fluorescence caused by binding of Sybr® Green Dye to the double-stranded DNA; Ct (cycle
threshold) values were calculated by SDS software v1.9 (Applied Biosystems). The absence of
nonspecific amplification was confirmed by analyzing PCR products by 2% (w/v) agarose gel.
In studies designed to identify an internal control to be used in analyses of BDNF gene
expression, we assessed the expression of several housekeeping genes (β-actin, cyclophilin A,
HPRT1, and 18S rRNA) using Ct values derived from Real-Time PCR. Reactions were
performed in triplicate. The relative quantification of the BDNF gene in different tissue samples
was determined using the 2-ΔΔCt method described by Livak and Schmittgen (2001). Initially, the
ΔCt value, the difference between the average of the triplicate Ct values for the BDNF and the
internal control β actin, for each sample was calculated (ΔCtsample = ΔCtBDNF – ΔCtβ actin). Next,
the average of the ΔCt values for the saccharin control animals (ΔCtSAC av) was determined and
subtracted from each sample (ΔCtsample – ΔCtSAC av), giving a ΔΔCt value for each. This is, in
turn, was used to calculate the 2-ΔΔCt value for each. Because 20 is one, the mean 2-ΔΔCt value for
the saccharin control samples was approximately one, depending on the variability in the
samples, and the mean 2-ΔΔCt value for the ethanol-exposed mouse samples was expressed
relative to one.
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RESULTS
Fetal Alcohol Exposure Paradigm
The present studies were conducted using C57BL/6J mice and the voluntary two-bottle choice
paradigm for prenatal ethanol exposure (Allan et al. 2003). The average consumption of ethanol
by the mothers of the mice used in the present studies was 9.55 (±2.57) g ethanol / kg body
weight / day. In a concurrent study, we found that the average maternal blood ethanol
concentration was 78 mg/dL in a group of C57BL/6 dams (n=7) whose average daily
consumption of ethanol was 8 g / kg body weight. Across six breeding rounds, we observed that
there were no differences between the weight gained by saccharin control or alcohol-consuming
dams, nor were there differences in litter size (Table 2).
Prenatal ethanol-exposed mice display increased learned helplessness
Learned helplessness is a long-standing test for assessing depressive behavior (Maier, 1984;
Caldarone et al., 2000; El Yacoubi and Vaugeois, 2007; McArthur and Borsini, 2006; Nestler et
al., 2002b). The learned helplessness procedure that was employed in the present studies
exposed saccharin control and ethanol-exposed mice to a series of inescapable footshocks, then
in a subsequent test session assessed whether the animals escaped the footshock, when given the
opportunity to do so; if escape occurred, the latency to escape was also recorded. The data for
the % of test subjects that escaped (Figure 1, left) were best fit by the equation for a hyperbola,
whereas the data for the escape latency (Figure 1, right) were best fit by a straight line.
Both saccharin and ethanol-exposed animals displayed increased escape behavior across the 28
testing trials, as demonstrated by an increased % of animals that escaped (Figure 1, left) and
decreased mean escape latencies (Figure 1, right) as testing progressed. The percentage of
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animals that escaped was greater for the saccharin control mice than for the ethanol-exposed
mice throughout the trials. Whereas nearly all of the control animals escaped from trial 15
onward, approximately 40-50% of the ethanol-exposed mice failed to escape in these later trials,
demonstrating learned helplessness, or depressive behavior. The similar slopes of the regression
lines fitting the escape latency data indicate that the rate of improvement in escape behavior was
similar in both groups. However, the line fitting the prenatal ethanol-exposed mouse data is
elevated relative to that for the saccharin data, indicating that ethanol-exposed mice displayed
increased learned helplessness behavior throughout the testing session. These results are
consistent with prenatal ethanol exposure being a risk factor for depression.
Prenatal ethanol-exposed mice display increased immobility in the Porsolt forced swim test
As a second test for depression, we assessed the behavior of ethanol-exposed and saccharin
control mice in the forced swim test, originally described by Porsolt et al. (1977). In this test, an
animal is placed into a container of water, with the level of water sufficiently high to prevent the
animal from touching the bottom of the container without submerging its body. Initially, the test
subject exhibits gross motor movements (swimming, climbing, and thrashing) that are indicative
of escape behavior, then eventually becomes relatively immobile, either floating or making only
small motor movements (twitching and kicking), which are indicative of a state of despair
(Porsolt et al., 1977). Figure 2 shows that, compared to saccharin control mice, mice exposed to
ethanol prenatally displayed increased immobility (i.e., increased depressive behavior) in the
forced swim test.
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Basal BDNF protein levels are reduced in the medial frontal cortex, but not the hippocampal
formation, of ethanol-exposed mice
Elevated learned helplessness susceptibility has been correlated with reduced basal BDNF levels
in the frontal cortex and hippocampal formation (Ridder et al., 2005), and infusions of BDNF
into the hippocampus (Shirayama et al., 2002), midbrain (Siuciak et al., 1997) or cerebral
ventricles (Hoshaw et al., 2005) produce antidepressant effects when animals are subsequently
tested in the learned helplessness (Shirayama et al., 2002; Siuciak et al., 1997) or forced swim
(Hoshaw et al., 2005; Shirayama et al., 2002; Siuciak et al., 1997) tests. Thus, we sought to
determine whether the observed increase in learned helplessness behavior and immobility in the
forced swim test of prenatal ethanol-exposed mice were accompanied by decreased BDNF
protein in the medial frontal cortex and/or hippocampal formation. Figure 3 shows that,
compared to saccharin control mice, BDNF levels were reduced in the ethanol-exposed mouse
frontal cortex, but not in the hippocampal formation.
Prenatal alcohol exposure reduces proBDNF levels in the medial frontal cortex
BDNF, like other neurotrophins, is synthesized in a precursor form, termed proBDNF (Lu 2003),
a 32-kDa protein that is cleaved to the 14-kDa mature BDNF (Mowla et al., 2001). BDNF is
formed extracellularly, by the action of plasmin (Pang et al., 2004), and intracellularly, both in
the trans-Golgi network by furin and in secretory granules by convertases, including PACE4 and
PACE5/6-B (Mowla et al., 2001; Seidah et al., 1996).
In order to begin addressing the mechanism(s) that underlies the observed decrease in BDNF
protein in the medial frontal cortex, we analyzed proBDNF protein levels in this brain region, as
well as in the hippocampal formation (Figure 4). Immunoblotting data showed that antiproBDNF immunoreactivity was decreased in the medial frontal cortex, but not the hippocampal
14

formation, of mice exposed prenatally to ethanol, thus paralleling the data for BDNF protein
levels.
Prenatal alcohol exposure is associated with reduced BDNF mRNA transcript levels in the
medial frontal cortex and hippocampal formation
We sought to determine whether reduced BDNF mRNA levels may contribute to the observed
decrease in medial frontal cortical proBDNF and BDNF protein. For these studies, it was
necessary to identify a suitable internal standard for semi-quantitative (relative) Real-Time PCR
analyses. Commonly used internal controls include β-actin, glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), cyclophilin A/B, HPRT1, and 18S rRNA. Several reports have found
effects of experimental manipulations on the expression of these genes (e.g., Maier et al., 1999;
Jang et al., 2005; Mogal and Abdulkadir, 2006; Verma and Shapiro, 2006; Tanic et al., 2007;
Nishimura et al., 2008). Prenatal ethanol exposure has been reported to alter β-actin expression
in embryos (Green et al., 2007) and neonatal cerebellum (Zoeller et al., 1994), but not neonatal
or adolescent intestine (Bhalla et al., 2004). We compared cyclophilin A, HPRT1, 18S rRNA,
and β-actin expression in saccharin control and prenatal ethanol-exposed adult hippocampal
formation and medial frontal cortex (Figure 5). Prenatal exposure to ethanol did not alter the
levels of β-actin or HPRT1 in either brain region, whereas it was associated with significantly
increased 18S rRNA levels in the hippocampal formation and reduced cyclophilin A levels in the
medial frontal cortex. Based on these data, we chose to use β-actin as an internal control during
analyses of BDNF transcript expression.
The mouse BDNF gene consists of multiple noncoding exons upstream of a common coding
exon (Figure 6A). Until recently, most studies had identified six exons in the mouse gene,
whereas Liu et al. (2006) identified eight exons and Aid et al. (2007) identified nine exons in the
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murine BDNF gene. We chose to follow the nomenclature of Aid et al. (2007). Exons are
designated using Roman numerals, according to their relative position, with I being the 5’-most
exon. Exons I-IXa are noncoding exons, while exon IX contains the open reading frame that
encodes proBDNF. In order to measure individual BDNF mRNA transcripts, we used PCR
primer pairs consisting of a forward primer specific for the upstream, non-coding exons I-VI,
excluding exon V, and a reverse primer specific for the coding exon IX. Figure 6B shows that,
in both the medial frontal cortex and hippocampal formation, prenatal ethanol exposure was
associated with significantly decreased levels of BDNF total mRNA (exon IX-containing
transcripts) and BDNF mRNA transcripts containing exon III, IV, or VI, but not those containing
exon I or II.
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CONCLUSIONS
FASD mice display depressive behaviors
We have identified increased learned helplessness, as well as increased immobility in a forced
swim test, in adult mice prenatally exposed to moderate levels of ethanol. Thus, using two well
accepted tests for behaviors that model depression, we found that prenatal ethanol exposure is
associated with depression in a mouse FASD model. As the escape response in the learned
helplessness test includes a learning component, it can be argued that the observed increase in
escape latency and escape failures in prenatal ethanol-exposed mice is a consequence of their
known learning impairments (Allan et al., 2003). However, this is refuted by our finding that the
slopes of the regression lines fitting the escape latency data for the ethanol-exposed and
saccharin mice were similar, indicating that the two groups learned the escape response at
comparable rates. The observed increased immobility in the forced swim test, which does not
involve learning, also supports our conclusion that prenatal ethanol-exposed mice display
behaviors that model depression. Finally, our findings in prenatal ethanol-exposed mice confirm
and extend those of Slone and Redei (2002), Wilcoxon et al. (2005), and Carneiro et al. (2005),
who reported that adults rats that were exposed prenatally to ethanol displayed increased
immobility in the forced swim test.
BDNF protein and mRNA levels are reduced in the brain of prenatal ethanol-exposed adult mice
Several hypotheses have been put forth regarding the genetic and biochemical bases of
depression (Hayley et al., 2005; Jans et al., 2007; Levinson, 2006; Nestler et al., 2002a). Many
of these have focused on mechanisms underlying the compromised functioning of the medial
frontal cortex and hippocampal formation which is observed in depressed individuals (Berton
and Nestler, 2006; Drevets, 2000; Johnstone et al., 2007; Phillips et al., 2003a,b). Consistent
17

with the neurotrophic hypothesis of depression, we found that proBDNF and BDNF protein
levels were reduced in the medial frontal cortex of prenatal ethanol-exposed mice; however,
proBDNF and BDNF protein levels were not different in the hippocampal formation of these
same animals. We also found that prenatal ethanol exposure was associated with reduced BDNF
total mRNA levels in both the medial frontal cortex and hippocampal formation. In both brain
regions, the levels of exon III-, IV-, and VI-containing transcripts were decreased, while the
levels of exon I- and II-containing transcripts were not different between ethanol-exposed and
saccharin control mice. Thus, in prenatal ethanol-exposed mice, the observed decrease in BDNF
mRNA levels correlated with reduced proBDNF and BDNF protein levels in the medial frontal
cortex; in contrast, in the hippocampal formation of prenatal ethanol-exposed mice, BDNF
mRNA levels were reduced, whereas proBDNF and BDNF protein levels were similar to those
found in saccharin mice. This indicates that proBDNF and BDNF protein levels are controlled
primarily by transcription in the medial frontal cortex, but post-transcriptionally in the
hippocampal formation. A similar lack of correlation between hippocampal BDNF mRNA and
protein levels has been reported by Nawa et al. (1995) and Greisen et al. (2005). Nawa et al.
(1995) reported that, following seizures, hippocampal BDNF protein levels remain elevated long
after mRNA levels have returned to baseline (Isackson et al., 1991). Greisen et al. (2005)
reported that maternal separation did not affect hippocampal formation BDNF mRNA levels but
increased BDNF protein levels in this brain region. Similarly, a lack of agreement between
BDNF mRNA and protein levels have been observed in the striatum and prefrontal cortex
following chronic cocaine administration in rats (Fumagalli et al., 2007).
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What mechanisms may underlie the observed decreases in specific BDNF transcripts?
Chronic defeat stress has been shown to decrease the expression of exon III- and IV-containing
transcripts in the hippocampal formation (Tsankova et al., 2006). Therefore, increased stress
levels may contribute to the observed reductions in exon III- and IV-containing transcripts in
prenatal ethanol-exposed mice, at least in the hippocampal formation. Interestingly, we have
reported that prenatal ethanol-exposed female mice have higher plasma corticosterone levels
than do saccharin controls (Allan et al., 2003), which could also account for the observed
decrease in exon VI-containing transcripts in the medial frontal cortex and hippocampal
formation, where the expression of exon VI-containing transcripts is repressed by corticosterone
(Dwivedi et al., 2006; Hansson et al., 2006). The expression of BDNF exon IV-containing
transcripts is controlled by the methylation of CpG dinucleotides in the promoter linked to exon
IV (Chen et al., 2003; Dennis and Levitt, 2005; Martinowich et al., 2003). Maier et al. (1999)
reported that prenatal ethanol exposure was associated with reduced BDNF mRNA levels in the
P10 rat olfactory bulb, and this reduction was correlated with hypermethylation of the BDNF
gene. Although these investigators did not demonstrate specific reductions in exon IVcontaining species or methylation of the exon IV promoter, their results suggest that the observed
decrease in BDNF mRNA containing exon IV in prenatal ethanol-exposed mice may be due to
increased methylation of CpG dinucleotides preceding the transcriptional initiation site for exon
IV. In addition to being controlled by methylation, the promoter for exon IV, as well as the
promoter associated with exon I, has a cAMP-responsive element (CRE) that binds cAMPresponsive element binding protein (CREB; Fang et al., 2003; Ou and Gean, 2007; Shieh et al.,
1998; Tabuchi et al., 2002; Tao et al., 1998). Thus, reduced levels of CREB activation in mice
that were exposed to ethanol prenatally could contribute to the observed reduction in the
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expression of exon IV-containing transcripts in these animals. However, the absence of an
observed effect of prenatal ethanol exposure on exon I-containing transcripts does not support a
role for global reductions in the level of activated CREB. The expression of BDNF transcripts
containing exon VI is regulated by extracellular signal-regulated protein kinase 2 (ERK2; Park et
al., 2006; Takeuchi et al., 2002). We have found that receptor-dependent activation of ERK2 in
hippocampal formation slices is impaired (Samudio-Ruiz, Valenzuela, Allan, and Caldwell;
unpublished observation). Therefore, reduced ERK2 activation could play a role in the observed
decrease in exon VI-containing transcripts in the hippocampal formation of ethanol-exposed
mice. Finally, acetylated histone H4 has been shown to regulate the expression of promoter VIcontaining transcripts in the medial frontal cortex (Bredy et al., 2007). We have found that
global levels of acetyl (Lys5, Lys8, Lys12, Lys16) histone H4 are reduced in the medial frontal
cortex, but not hippocampal formation, of prenatal ethanol-exposed mice (Caldwell and Allan,
unpublished observation), implicating reduced binding of acetylated histone H4 at the promoter
for BDNF exon VI as a candidate mechanism underlying the observed reduced level of exon VIcontaining transcripts in the medial frontal cortex of the prenatal ethanol-exposed mice.
Evidence exists that does not support a role for BDNF in depression
Although several lines of research indicate that BDNF plays an important role in depression, it
should be noted that evidence exits that does not support this conclusion. Angelucci et al. (2000)
reported that, compared to the Flinders Resistant Line (FRL), the Flinders Sensitive Line (FSL)
rats, which display a variety of depressive behaviors, have increased basal BDNF protein levels
in the frontal cortex, but not the hippocampal formation. Hellweg et al. (2007) have reported
that olfactory bulbectomy, which has been proposed as a rodent model of depression, leads to
increased BDNF protein levels in the hippocampal formation and frontal cortex of mice. Thus,
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Hellweg et al. (2007) have proposed that BDNF contributes only to certain types of depressive
states, or only under certain conditions in laboratory models of depression. Finally, Greenwood
et al. (2007) have found that learned helplessness does not depend on hippocampal formation
BDNF. This last observation is consistent with our finding of unaltered BDNF protein in the
hippocampal formation of prenatal ethanol-exposed mice compared to saccharin controls, yet
FASD mice display elevated learned helplessness behavior.
Relevance to pharmacologic management of clinical depression in FASD patients
The present studies may have relevance to the choice of antidepressant for the treatment of
FASD-associated depression. Chronic tranylcypromine treatment has been shown to increase
BDNF protein levels in the rat frontal cortex, but not the hippocampal formation, whereas
fluoxetine and desipramine did not affect medial frontal cortical BDNF protein levels (Altar et
al., 2003). Dwivedi et al. (2006) reported that chronic phenelzine and desipramine increased
BDNF mRNA in both the frontal cortex and hippocampal formation, while fluoxetine increased
BDNF only in the hippocampal formation. Dias et al. (2003) found that chronic desipramine
increased the levels of BDNF exon III-containing transcripts in the piriform cortex and inner and
outer layers of the neocortex; in contrast, fluoxetine was without effect in these regions.
Okamoto et al. (2003) found that chronic amitriptyline increased BDNF protein levels in the
hippocampal formation and frontal cortex. Thus, drugs shown to increase BDNF mRNA or
protein levels in the frontal cortex, such as tranylcypromine, amitriptyline, phenelzine, and
possibly desipramine, may be effective in treating depressive symptoms in FASD patients,
whereas fluoxetine may be less effective.
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Conclusions
These studies demonstrate that prenatal ethanol-exposed mice display depressive behaviors,
when tested as adults. Additionally, adult offspring that had been exposed to ethanol prenatally
had reduced BDNF mRNA and protein levels in the medial frontal cortex and BDNF mRNA
levels in the hippocampal formation. These data demonstrate that prenatal ethanol exposureassociated depression and alterations in brain BDNF are correlated. Although they do not
provide direct evidence that these reductions in BDNF are an underlying cause of the observed
depression, the data are consistent with the neurotrophic hypothesis of depression and indicate
that the hypothesis may be extended to include FASD-associated depression. In order to
determine whether reductions in BDNF play a causative role in prenatal ethanol-associated
depression, future studies will need to identify the developmental stage at which prenatal ethanol
exposure exerts it effects on BDNF expression and test the behavioral consequence of reversing
these effects (e.g., through targeted overexpression of BDNF). The results of the present study
do, however, support the use of antidepressants that have been shown to increase frontal cortical
BDNF in the treatment of FASD-associated depression.
It is possible that the effects of prenatal ethanol exposure on BDNF mRNA are, at least in part,
mediated by, or secondary to, changes in serotonergic neurotransmission. Several investigators
have reported that developing serotonergic neurons are highly vulnerable to the damaging effects
of ethanol (Rathbun and Druse, 1985; Sari and Zhou, 2004; Tajuddin, and Druse, 1993, 1999;
Zhou et al., 2002, 2005). These ethanol-induced decreases in 5-HT levels and neurons are likely
to have a significant cascading effect on the developing nervous system as a whole, thereby
impacting BDNF. Additionally, as noted previously, several antidepressants, including
serotonin-selective reuptake inhibitors (SSRIs), have been shown to modify BDNF levels in the
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prefrontal cortex and hippocampus. Thus, future studies will aim to determine the contribution
of reduced serotonergic neurotransmission to the observed alterations in BDNF levels.
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TITLES AND LEGENDS TO FIGURES
Figure 1 Prenatal ethanol-exposed mice display increased learned helplessness. Learned
helplessness behavior was assessed as described in the Methods section. Data are graphed as a
function of trial number; saccharin control (SAC) and ethanol-exposed (fetal alcohol spectrum
disorder, FASD) mice (n=8) were used in this study. Left: Percentage of animals that escaped.
The data were fit to the equation of a hyperbola using GraphPad Prism (version 4.0); the best-fit
curves are shown. The curves fitting the saccharin control and prenatal ethanol-exposed data
sets were significantly different from each other [F(2,52)=44.0, p<0.0001]. Right: Mean + SEM
escape latencies Comparisons of different models [polynomial first order (straight line), one
phase exponential decay curve, two phase exponential decay curve, hyperbola (one site binding)]
using GraphPad Prism (version 4.0) found that both data sets were best fit by a polynomial first
order (straight line). Linear regression analyses of the two data sets revealed that the slopes of
the two lines were not different but the intercepts were significantly different [F(1,445)=33.0,
p<0.01].

Figure 2 Prenatal ethanol-exposed mice display increased immobility in the forced swim test.
Time spent in immobile behaviors, (floating, twitching, kicking) in seconds for saccharin (SAC)
control (n=8) and prenatal ethanol-exposed (fetal alcohol spectrum disorder, FASD) (n=8) mice
during the last two minutes of the three minutes of the swim task. t(14)=8.41, * indicates
p<0.0001.
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Figure 3 Prenatal ethanol exposure is associated with reduced BDNF levels in the medial
frontal cortex, but not hippocampal formation, of mice. Homogenates of the medial frontal
cortex (MFC) and hippocampal formation (HPF) were prepared from adult saccharin (SAC)
(n=8) and prenatal ethanol-exposed (fetal alcohol spectrum disorder, FASD) (n=7) mice and
BDNF levels were quantified by ELISA. Data were expressed relative to the wet weight of the
tissue sample. Compared to BDNF levels present in the medial frontal cortex of saccharin
control mice, BDNF levels were significantly reduced in the medial frontal cortex of prenatal
ethanol-exposed mice: t(13)=2.7, * indicates p<0.02.

Figure 4 Prenatal ethanol exposure is associated with reduced proBDNF levels in the medial
frontal cortex, but not the hippocampal formation. Postnuclear (1,000 gmax, 6 min) fractions
were prepared from the medial frontal cortex (MFC) and hippocampal formation (HPF) of adult
saccharin (SAC; n=6 for HPF; n=8 for MFC) and prenatal ethanol-exposed (fetal alcohol
spectrum disorder, FASD) (n=6 for HPF; n=11 for MFC) mice. proBDNF levels were analyzed
by immunoblotting (see Methods). Data are presented as arbitrary units (defined as the adjusted
volume measurement obtained from the immunoblot images divided by the amount of protein
loaded onto the gel). Compared to proBDNF levels in the medial frontal cortex of saccharin
control mice, proBDNF levels were significantly reduced in the medial frontal cortex of prenatal
ethanol-exposed mice: t(17)=2.44, * indicates p<0.02.

Figure 5. Expression of housekeeping genes, cyclophilin A, HPRT1, 18S rRNA, and β-actin, in
saccharin control and prenatal ethanol-exposed adult mouse hippocampal formation and medial
frontal cortex. Levels of mRNA transcripts for cyclophilin A, HPRT1, 18S rRNA, and β-actin
38

were determined as described in the Methods. Cycle threshold (Ct) values were determined in
triplicate for prenatal ethanol-exposed (fetal alcohol spectrum disorder, FASD) (n=8) and
saccharin (SAC) control (n=8) samples in both the hippocampal formation (HPF) and medial
frontal cortex (MFC). Statistical significance was determined using a two-tailed t-test:
cyclophilin A SAC vs. FASD in the MFC, t(14) = 5.16; 18S rRNA SAC vs. FASD in the HPF,
t(14) = 3.64. ** designates p<0.01.

Figure 6 A. Mouse BDNF gene structure. Boxes represent exons and lines connect splice
variants analyzed in Figure 5B. Exon IX (shaded) contains the open reading frame encoding
proBDNF. B. Levels of BDNF total (exon IX-containing) and specific mRNA transcripts in the
medial frontal cortex (MFC) and hippocampal formation (HPF) of saccharin control (SAC) and
prenatal ethanol-exposed (fetal alcohol spectrum disorder, FASD) mice. Real Time PCR was
performed and data calculated as described in the Methods. Compared to SAC control (n=8),
prenatal ethanol-exposed mice (n=8) mice had significantly reduced levels of exons III [MFC,
t(14)=2.8; HPF, t(14)=4.2], IV [MFC, t(14)=8.1; HPF, t(14)=6.2], VI [MFC, t(14)=8.6; HPF,
t(14)=3.6], and IX [MFC, t(14)=3.7; HPF, t(14)=3.9]. * indicates p<0.02; ** indicates p<0.01.
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Target
BDNF exon I
BDNF exon II
BDNF exon III
BDNF exon IV
BDNF exon VI
BDNF exon IX
β-actin
Cyclophilin A
HPRT1
18S rRNA

Forward primer

Reverse primer

CCTGCATCTGTTGGGGAG
GGGTTGGTATACTGGGTT
GGGCCGGATGCTT
CAGAGCAGCTGCCTTGAT
CTGCCACCACTGCCTTGG
CAGGTGAGAAGAGTGATGACC
CCATCATGAAGTGTGACGTGG
TGCTGGACCAAACACAAACG
AAGACTTGCTCGAGATGTCATGAA
CGGCTACCACATCCAAGGAA

GCCTTGTCCGTGGACGTTT
GGATGGTCATCACTCTTCTC
CCGTGGACGTTTACTTC
GCCTTGTCCGTGGACG
GGATGGTCATCACTCTTC
ATTCACGCTCTCCAGAGTCCC
GTCCGCCTAGAAGCATTTGCG
GCCTTCTTTCACCTTCCCAAA
ATCCAGCAGGTCAGCAAAGAA
CCTGTATTGTTATTTTTCGTCACTACCT

Table1. Sequences (5′→3′) of the forward and reverse primer pairs used for PCR amplification.
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Prenatal
diet/exposure
SAC
ethanol

Maternal weight at
beginning of drinking (g)
20.97 (±2.63)
21.50 (±3.23)

Maternal weight Day
6-7 after birth (g)
29.91 (±2.22)
29.20 (±3.23)

Litter size
5.9 (±2.29)
6.3 (±1.99)

Table 2. Maternal weights and litter sizes for saccharin (SAC) control and ethanol-consuming
mice. Maternal weights were determined at the beginning of the drinking paradigm, as well as
throughout drinking, and on postpartum day 6-7. Litter sizes were determined on Day 6-7 after
delivery. The data are from six separate breeding rounds and are expressed as mean ± SEM;
SAC (n=47) and ethanol (n=50) dams.

47

